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Stat6 Is Required for Mediating Responses
to IL-4 and for the Development of Th2 Cells
Mark H. Kaplan,* Ulrike Schindler,² of immunoglobulin E (IgE) synthesis by activated B lym-
phocytes and influences class switching to IgG1 as wellStephen T. Smiley,* and Michael J. Grusby*³
(Vitetta et al., 1985; Coffman et al., 1986). B cells stimu-*Department of Cancer Biology
lated with IL-4 increase their cell surface expression ofHarvard School of Public Health
major histocompatibility complex (MHC) class II mole-Boston, Massachusetts 02115
cules (Noelle et al., 1984), IL-4 receptor (IL-4R) (Ohara²Tularik, Incorporated
and Paul, 1988), and the low affinity IgE receptor, CD23270 East Grand Avenue
(Conrad et al., 1987). IL-4 also induces the proliferationSouth San Francisco, California 94080
of T lymphocytes and is important for the differentiation³Department of Medicine
of T helper 2 (Th2) cells (Le Gros et al., 1990; Swain etHarvard Medical School
al., 1990). Indeed, the analysis of IL-4-deficient miceBoston, Massachusetts 02115
generated by gene targeting in embryonic stem (ES)
cells has confirmed the importance of this cytokine in
mediating many of these responses (Kuhn et al., 1991;
Kopf et al., 1993).Summary
IL-4-induced responses result from the interaction of
ligand with a cell surface receptor composed of a cyto-Interleukin-4 (IL-4) stimulation of cells leads to the
kine-specific a chain and the common gc chain alsoactivation of multiple signaling pathways, one of which
used by IL-2 (Takeshita et al., 1992), IL-7 (Noguchi etinvolves Stat6. We have generated Stat6-deficient
al., 1993; Kondo et al., 1994), IL-9 (Russell et al., 1994),mice by gene targeting in embryonic stem cells to
and IL-15 (Giri et al., 1994) receptors. Recent studiesdetermine the role of this transcription factor in medi-
have shown that the a chain of the IL-4R is also a compo-ating the biologic functions of IL-4. IL-4-induced in-
nent of the high affinity IL-13 receptor (Lin et al., 1995;creases in the cell surface expression of both MHC
Zurawski et al., 1995; Hilton et al., 1996). Engagementclass II antigens and IL-4 receptor are completely ab-
of the IL-4R leads to the activation of at least two distinctrogated, and lymphocytes from Stat6-deficient ani-
signaling pathways. One involves the activation of Stat6mals fail to proliferate in response to IL-4. Stat6-defi-
through phosphorylation by Jak1 and Jak3 (Johnstoncient B cells do not produce IgE following in vivo
et al., 1994; Witthuhn et al., 1994). The Stat pathway isimmunization with anti-IgD. In addition, Stat6-deficient
thought to be important because the promoters of sev-T lymphocytes fail to differentiate into Th2 cells in
eral genes known to be regulated by IL-4 contain theresponse to either IL-4 or IL-13. These results demon-
consensus Stat6-binding site TTCN4GAA (Schindler etstrate that, despite the existence of multiple signaling
al., 1995), and fragments of promoters of Ie and other
pathways activated by IL-4, Stat6 is essential for medi-
genes containing this sequence bind Stat6 present in
ating responses to IL-4 in lymphocytes. extracts from cells stimulated with IL-4 (Ichiki et al.,
1993; Kotanides and Reich, 1993; Schindler et al., 1994).
In addition to Stat6 activation, stimulation of the IL-4RIntroduction
has also been shown to induce the phosphorylation of
an insulin receptor substrate (IRS) termed 4PS or IRS-2Signal transducers and activators of transcription
(Keegan et al., 1994; Sun et al., 1995). Activated IRS-2(STAT) proteins are a recently identified class of tran-
associates with phosphatidylinositol 3-kinase and may
scription factors responsible for mediating many cyto-
be responsible for certain IL-4-induced responses. For
kine-induced responses. These proteins exist in a latent
example, cell lines transfected with an IL-4R mutant that
form in the cytoplasm and become phosphorylated by
is incapable of inducing the tyrosine phosphorylation of
the Janus kinase (JAK) family of tyrosine kinases follow- IRS-2 have an impaired ability to proliferate in response
ing cytokine±receptor interactions. Once phosphory- to IL-4 (Keegan et al., 1994).
lated, STAT proteins dimerize, translocate to the nu- To determine the relative importance of the Stat6 sig-
cleus, and bind to specific DNA sequences to regulate naling pathway in mediating the biologic functions of
gene transcription (Ihle, 1995; Schindler and Darnell, IL-4, we have produced mice deficient in Stat6. Our
1995). Of the presently known STAT proteins, only Stat6 results demonstrate that lymphocytes from Stat62/2
is activated in response to the cytokine interleukin-4 mice are unable to respond to IL-4 as measured in a
(IL-4) (Kotanides and Reich, 1993; Hou et al., 1994; variety of in vitro and in vivo assays. Furthermore,
Schindler et al., 1994; Quelle et al., 1995). Stat62/2 mice show a striking defect in the generation of
IL-4 is secreted by several cell types including stimu- Th2 cells. These results suggest that the Stat6 signaling
lated T lymphocytes, mast cells, and basophils (Howard pathway is critical for mediating IL-4-induced responses
et al., 1982; Lee et al., 1986; Paul and Ohara, 1987; in lymphocytes.
Yoshimoto and Paul, 1994; Sad et al., 1995). While ini-
tially identified by its ability to support the growth and Results and Discussion
differentiation of B lymphocytes costimulated with sub-
mitogenic doses of anti-immunoglobulin (Howard et al., Generation of Stat6-Deficient Mice
1982), IL-4 is now known to have pleiotropic effects on A gene-targeting construct was generated that replaces
exons encoding amino acids 505±584 of Stat6 with athe immune system. IL-4 is essential for the induction
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Figure 1. Generation and Analysis of Stat62/2
Mice
(A) Schematic of the targeting construct used
to disrupt the Stat6 gene. The two exons of
the Stat6 gene that were replaced with the
neomycin resistance gene are indicated as
closed bars and the positions of other exons
are not shown. 59 and 39 probes used to verify
correctly targeted clones are indicated under
the mutant allele. Restriction enzymes are the
following: B, BamHI; Bg, BglI; H2, HindII.
(B) Southern (DNA) analysis of tail DNA from
an intercross litter digested with BamHI and
hybridized with the 59 probe indicated in (A).
The approximate size of the wild-type band
is 3.5 kb and the mutant band is 1.9 kb.
(C) Immunoblot analysis of total cell extracts
from spleen and thymus of mice wild-type,
heterozygous, or homozygous-deficient for
the Stat6 gene. As a control, filters were also
probed with an antibody specific for Stat1.
cassette containing the neomycin resistance gene (Fig- on lymphocytes in response to IL-4 (Noelle et al., 1984;
Ohara and Paul, 1988). To examine the role of Stat6 inure 1A). This region of the Stat6 gene encodes the SH2
domain required for Stat dimerization, thereby insuring the regulation of IL-4-inducible genes, lymph node cells
from control or Stat62/2 mice were incubated for 18 hrthat any mutant protein that may be made from the
targeted locus will not be functional. The targeting con- in 1,000 U/ml IL-4 and then examined by flow cytometry.
As shown in Figure 2, B cells from control mice show astruct was electroporated into D3 ES cells, and Southern
(DNA) analysis of G418-resistant clones revealed that 6 striking increase in their cell surface expression of MHC
of 60 clones had undergone homologous recombination
at the Stat6 locus. Correctly targeted clones were in-
jected into BALB/c blastocyts to generate chimeras.
Once the disrupted Stat6 allele was transmitted through
the germline, heterozygotes were intercrossed to gener-
ate mice homozygous for the Stat6 mutation (Figure 1B).
Despite the widespread expression of Stat6 transcripts
in adult tissues (Hou et al., 1994), Stat62/2 mice are
grossly indistinguishable from their control littermates.
Immunoblot analysis of cell lysates from both spleen
and thymus confirmed that Stat62/2 mice do not express
Stat6 protein (Figure 1C). All lymphocyte subsets in the
thymus and peripheral lymphoid organs of Stat62/2 mice Figure 2. Flow Cytometric Analysis of Lymphocytes From Control
appear to be represented normally when analyzed by and Stat62/2 Mice
flow cytometry for CD3, CD4, CD8, and B220 (data not Lymph node cells from heterozygousor Stat6 homozygous-deficient
shown). mice were incubated for 18 hr in either medium alone (fine lines) or
medium plus 1,000 U/ml IL-4 (bold lines). Cells were stained with
either a cocktail of antibodies specific for I-Ad, I-Ed, and I-Ab andStat6 Is Required for IL-4-Induced Increases
analyzed for MHC class II expression on B2201 cells (left) or with
in the Expression of Cell Surface Markers an antibody specific for the a chain of the IL-4R (right). Log fluores-
Several cell surface molecules, including MHC class II cence intensity is shown on the X axis and cell number on the Y
axis.antigens and the IL-4R are known to be up-regulated
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class II molecules in response to stimulation with IL-4,
while both B and T cells demonstrate an increase in the
expression of IL-4R. In contrast, no induction of these
genes is seen in lymphocytes from Stat62/2 mice in
response to IL-4. The basal level of expression of these
genes on lymphocytes from control and Stat62/2 mice
is similar, and lipopolysaccharide stimulation of B lym-
phocytes from Stat62/2 mice and their control lit-
termates leads to an equivalent up-regulation in the cell
surface expression of MHC class II antigens (data not
shown). These results demonstrate that Stat6 is required
for the IL-4-induced increase in expression of genes
regulated by this cytokine.
Lymphocytes From Stat62/2 Mice Have
a Greatly Impaired Proliferative
Response to IL-4
As mentioned above, cell lines transfected with an IL-
4R mutant that is incapable of inducing the tyrosine
phosphorylation of IRS-2 have an impaired ability to
proliferate in response to IL-4 (Keegan et al., 1994). Simi-
lar transfectants containing a truncated IL-4R incapable
of mediating the tyrosine phosphorylation of Stat6 retain
their mitogenic response to IL-4 (Keegan et al., 1994;
Quelle et al., 1995). These results suggested that the
IRS-2 signaling pathway, rather than the Stat6 pathway,
is important for the proliferative response to IL-4. To
examine more definitively the role of Stat6 in mediating
the proliferation of lymphocytes in response to IL-4,
lymph node cells from Stat62/2 mice and control lit-
termates were stimulated for 48 hr in the presence of
graded doses of IL-4 and subsequently assayed for
[3H]thymidine incorporation. As shown in Figure 3A, the
proliferative response of lymphocytes from Stat62/2
mice is almost completely abrogated. In contrast with
lymphocytes from control mice, which show a 40-fold
increase in proliferation in response to 1,000 U/ml IL-4,
the proliferative response of lymphocytes from Stat62/2
mice is only 4- to 5-fold over background at this concen-
Figure 3. Proliferation of Lymphocytes from Control or Stat62/2 in
tration of IL-4 and undetectable at 100 U/ml IL-4. No Response to IL-4 or IL-2
differences wereobserved in the proliferationof lympho- Lymph node cells were stimulated with increasing doses of either
cytes from Stat62/2 mice or control littermates to graded (A) IL-4 or (B) IL-2 for 48 hr and pulsed for the last 18 hr of culture
doses of IL-2, whose receptor uses the same gc chain with [3H]thymidine. Symbols indicate the mean of triplicate wells 6
SEM.as IL-4 (Figure 3B), or in their proliferation in response to
either anti-CD3 or lipopolysaccharide (data not shown).
It is noteworthy that the ability of mutant forms of the
IL-4R both to induce the phosphorylation of signaling the proliferative response. Additional studies will be re-
quired to address this issue. Nevertheless, our datamolecules and to generate a proliferative response was
assayed using transfectants of a myeloid progenitor cell clearly demonstrate that a normal IL-4-induced prolifer-
ative response in lymphocytes is dependent on Stat6.line (Keegan et al., 1994; Quelle et al., 1995). Therefore,
the apparently greater importance of IRS-2 in mediating Furthermore, these results are consistent with previous
observations suggesting that STAT proteins may be in-proliferative signals in myeloid cells in response to IL-4
may reflect differences in the cell types examined. How- volved in transformation and cell growth (Danial et al.,
1995; Migone et al., 1995; Yu et al., 1995).ever, these results do not preclude a role for IRS-2 in
mediating the proliferative signal in lymphocytes. In-
deed, the small amount of proliferation of Stat62/2 lym- Stat6 Is Required for the Generation
of an IgE Responsephocytes to high concentrations of IL-4 may be due to
signals generated through other pathways, such as that IL-4 has been demonstrated to be essential for the gen-
eration of IgE in response to a number of antigenicinvolving IRS-2. Additionally, we cannot rule out the pos-
sibility that the reduced proliferation of Stat62/2 lympho- challenges, including immunization with anti-IgD (Con-
rad et al., 1990; Finkelman et al., 1991). To analyze thecytes in response to IL-4 results from the inability of
IL-4 to induce the up-regulation of IL-4R and amplify role of Stat6 in this IL-4-mediated response, Stat62/2
Immunity
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Figure 4. Analysis of Immunoglobulin Iso-
type Production by Control and Stat62/2 B
Lymphocytes
Control (open bars) and Stat62/2 (stippled
bars) mice were immunized with 200 mg anti-
IgD and bled 9 days after injection. Immuno-
globulin isotypes in pre- and post-bleeds
were quantitated by ELISA. Concentrations
of antibody are shown in micrograms/milli-
liter.
mice and control littermates were injected with IgD- Stat62/2 mice demonstrated an inability to produce IL-4
and IL-5 when cultured under identical conditions (Fig-specific monoclonal antibodies. All mice, regardless of
ure 5B). Thus, T lymphocytes from Stat62/2 mice aretheir genotype, developed splenomegaly in response to
almost completely impaired in their ability to differenti-immunization with anti-IgD (data not shown). Sera were
ate into Th2 cells, a result consistent with the notionanalyzed by enzyme-linked immunosorbent assay
that Stat6 is essential for mediating the differentiation(ELISA) for the presence of all immunoglobulin isotypes
signals induced by IL-4.both before immunization and 9 days postinjection with
It is noteworthy that the impairment in Th2 develop-anti-IgD. As shown in Figure 4, the basal levels of IgM,
ment seen in Stat62/2 mice is more pronounced thanIgG1, and IgG2a were similar between Stat62/2 mice
that observed in IL-4-deficient mice. Despite the impor-and control littermates. Following immunization with
tance of IL-4 in mediating the differentiation of Th2 cells,anti-IgD, control mice show an increase in serum levels
the limited generation of these cells can be detected inof each of these immunoglobulin isotypes and, consis-
IL-4-deficient mice in response to infection with Nippo-tent with previous reports, a striking induction in the
strongylus brasilienis (Kopf et al., 1993) and followinglevel of IgE is evident. While sera from Stat62/2 mice
in vitro differentiation (M. H. K. and M. J. G., unpublishedimmunized with anti-IgD show an increase in the levels
data). The more profound defect in Th2 developmentof IgG1 and IgG2a similar to that seen in the sera of
seen in Stat62/2 mice suggests that a cytokine otherimmunized control mice, Stat62/2 mice did not have
than IL-4 may be capable of inducing the differentiationdetectable levels of IgE. The inductionof IgG1 in Stat62/2
of Th2 cells, but that, like IL-4, this cytokine generatesmice is not surprising, since IL-4-deficient mice also
differentiation signals through Stat6. IL-13 is one suchhave detectable levels of IgG1 (Kuhn et al., 1991) and,
candidate, since this cytokine shares many propertieswe have noted, an increase in serum IgG1 following anti-
with IL-4. Recent studies have shown that the a chainIgD injection is seen in IL-4-deficient mice and therefore
of the IL-4R is also involved in the formation of the highis not dependent on IL-4 (M. H. K. and M. J. G., unpub-
affinity IL-13 receptor (Lin et al., 1995; Zurawski et al.,lished data).
1995; Hilton et al., 1996). Furthermore, while IL-13 does
not induce T cell proliferation, IL-13 stimulation doesT Lymphocytes From Stat62/2 Mice Do Not
lead to the tyrosine phosphorylation of Stat6 (M. H. K.,
Differentiate Into Th2 Cells
U. S., and M. J. G., unpublished data).
To address directly the role of Stat6 in the differentiation To determine whether IL-13 is capable of inducing
of Th cell subsets, spleen cells from control and Stat62/2
the differentiation of Th2 cells and, if so, whether this
mice were stimulated in vitro with anti-CD3 and cultured process is mediated by Stat6, spleen cells from control
in the presence of either IL-12 and anti-IL-4 to generate and Stat62/2 mice were stimulated in vitro with anti-CD3
Th1 cells, or IL-4 and anti-interferon-g (IFNg) to generate and cultured in the presence of IL-13 and anti-IFNg.
Th2 cells. After 1 week in culture, cells were washed, As shown in Figure 5C, lymphocytes from control mice
restimulated with anti-CD3, and culture supernatants stimulated in the presence of IL-13 developed into Th2
were assayed for the presence of various cytokines by cells, as evidenced by their production of high levels
ELISA. Th1 cell differentiation is unimpaired in Stat62/2 of IL-4 and IL-5 following subsequent restimulation. In
mice as evidenced by their ability to produce similar contrast, IL-13 was not capable of generating Th2 cells
amounts of IFNg and granulocyte/macrophage colony- from Stat62/2 lymphocytes. These results demonstrate
stimulating factor compared with that produced by con- that IL-13 is indeed capable of inducing the differentia-
trol cells cultured under identical conditions (Figure 5A). tion of Th2 cells, and that Stat6 is essential for the differ-
As expected, barely detectable levels of IL-4 and IL-5 entiation signals generated by both IL-4 and IL-13 in
are produced by cells cultured under Th1-inducing con- T cells. Furthermore, the ability of IL-13 to drive the
ditions irrespective of their genotype (data not shown). differentiation of Th2 cellsmay account for the presence
When lymphocytes from control mice were cultured un- of Th2 responses in IL-4-deficient mice.
der conditions that favor the generation of Th2 cells and Taken together, our results with Stat62/2 mice demon-
subsequently assayed for their ability to produce IL-4 strate a critical role for this transcription factor in mediat-
and IL-5, they were found to secrete high levels of these ing IL-4-induced responses in lymphocytes. Other sig-
naling pathways, including that involving the tyrosinecytokines (Figure 5B). In contrast, lymphocytes from
IL-4-Induced Responses in Stat6-Deficient Mice
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results may be explained by the observation that, like
IL-4, IL-13 is also capable of inducing the Stat6-depen-
dent differentiation of Th2 cells. Stat62/2 mice will be
useful in identifying genetic programs necessary for the
development of Th2 cells.
Experimental Procedures
Stem Cells and Blastocyst Injections
A gene targeting construct containing approximately 1 kb of 59
flanking sequence and 3 kb of 39 flanking sequence of the Stat6
gene was generated.The targeting construct (20 mg) was electropor-
ated into D3 ES cells using a Bio-Rad gene pulser set at 25 mF/350
V. After 9 days of selection in 180 mg/ml G418 and 2 mM gancyclovir,
drug-resistant clones were picked into 24-well plates and expanded
in culture. Screening for correctly targeted clones was done by
Southern (DNA) analysis and, once identified, they were injected
into 3.5 day postcoital BALB/c blastocysts.
Immunoblot Analysis
Total cellular extractswere prepared as previously described(Quelle
et al., 1995), except that following centrifugation, extracts were dia-
lyzed against 1 XD (Dignam et al., 1983). Protein (20 mg) was sepa-
rated on an 8% polyacrylamide gel, and electrophoretically trans-
ferred onto nitrocellulose. The filter was blocked in 10% dry milk in
13 TBST for 14 hr and subsequently probed with antisera directed
against recombinant Stat6 (Schindler et al., 1995) at a 1:10,000 dilu-
tion for 1 hr. Stat1 anti-serum was produced against the C-terminal
33 aa (Schindler et al., 1995). Protein bands were detected by en-
hanced chemiluminescence (Amersham, Arlington Heights, Illinois).
Antibodies and Cytokines
Antibodies to CD3 (145-2C11) and fluorescein isothiocyanate± and
phycoerythrin-conjugated antibodies to I-Ad, I-Ed, I-Ab, and B220
were purchased from Pharmingen (San Diego, California). Recombi-
nant IL-4 and antibody specific for IL-4R were purchased from Gen-
zyme (Cambridge, Massachusetts). A fluorescein isothiocyanate±
conjugated goat anti-rat immunoglobulin was purchased from KPL
(Gaithersburg, Maryland) and used as a secondary reagent for the
IL-4R antibody. Mouse monoclonal antibodies specific for IgDa (Fin-
kelman et al., 1991) were the gift of Dr. F. Finkelman. Anti-IL4 (11B11)
was the gift of Dr. W. Paul. Anti-IFNg was purified from supernatant
of the XMG-1 hybridoma. Recombinant IL-2 was obtained from Boe-
hringer-Mannheim (Indianapolis, Indiana). Recombinant IL-12 was
the gift of Dr. M. Gately. Recombinant IL-13 was purchased from R
and D Systems (Minneapolis, Minnesota).
Figure 5. Cytokine Analysis of In Vitro Differentiated T Lymphocytes
from Control and Stat62/2 Mice
Flow CytometrySpleen cells from control and Stat62/2 mice were activated with
Single cell suspensions were made from the indicated tissues. Cells
anti-CD3 and cultured underconditions that skew their development
(1 3 106) were incubated on ice with 1 mg monoclonal antibody for
towards either (A) Th1 cells (IL-12 plus anti-IL-4), (B) Th2 cells (IL-4
1 hr and washed before analysis on a Becton-Dickenson FACScan.
plus anti-IFNg), or (C) Th2 cells (IL-13 1 anti-IFNg). After 7 days in
culture, cells were restimulated with anti-CD3 and supernatants
Proliferation Assayswere collected 24 hr later and analyzed for the presence of cytokines
Lymph node cells were plated at 5 3 104/round-bottomed microwellby ELISA. The amount of IL-4 and IL-5 produced by Th2-differenti-
with dilutions of the indicated lymphokine in RPMI 1640 (Mediatech,ated cells from Stat62/2 mice was at or below the level of detection
Herndon, Virginia) supplemented with 10% fetal calf serum (Hyclone,(2 ng/ml, IL-4; 50 U/ml, IL-5).
Logan, Utah), penicillin±streptomycin, sodium pyruvate, nonessen-
tial amino acids, L-glutamine, HEPES (all from Mediatech) and 5 3
1025 M 2-mercaptoethanol. Cells were pulsed with 1 mCi [3H]thymi-
phosphorylation and activation of other STATs or IRS-2, dine (New England Nuclear, Boston, Massachusetts) for the last 18
hr of a 48 hr culture period. Spleen cells were incubated at 105/wellclearly cannot compensate for Stat6. The role of these
for lipopolysaccharide and anti-CD3 stimulations.latter pathways in mediating cytokine responses in both
lymphocytes and other hematopoietic cells remains to
In Vivo IgE Productionbe determined.
Mice were injected with 100 mg of two anti-allotypic anti-IgD mono-Our results also suggest that Stat6 is required for
clonals in 200 ml phosphate-buffered saline. Mice were bled by themediating the differentiation signals leading to the de-
tail vein to obtain preimmunization serum. At 9 days postinjection,
velopment of Th2 cells in response to IL-4. Interestingly, mice were sacrificed and bled by cardiac puncture. Immunoglobulin
the defect in Th2 development seen in Stat62/2 mice is isotypes were analyzed by ELISA as previously described (Marko-
witz et al., 1993).more severe than that seen in IL-4-deficient mice. These
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In Vitro T Cell Differentiation Paul, W.E. (1994). An IL-4 receptor region containing an insulin re-
ceptor motif is important for IL-4 mediated IRS-1 phosphorylationFor in vitro differentiation assays, 2 3 106 spleen cells/ml were
cultured in medium as above and stimulated with 1 mg/ml plate- and cell growth. Cell 76, 811±820.
bound anti-CD3 and incubated with 10 mg/ml anti-IL-4 plus 100 U/ Kondo, M., Takeshita, T., Higuchi, M., Nakamura, M., Sudo, T., Nishi-
ml IL-12 (Th1) or 10 mg/ml anti-IFNg (Th2). After activation (24 hr), kawa, S.-I., and Sugamura, K. (1994). Functional participation of
we added 50 U/ml of IL-2 to all cultures and 1,000 U/ml IL-4 or 25 the IL-2 receptor g chain in IL-7 receptor complexes. Science 263,
pg/ml IL-13 to Th2 cultures. Cultures were supplemented with fresh 1453±1454.
medium after 4 days, washed, and restimulated after 7 days with
Kopf, M., Le Gros, G., Bachmann, M., Lamers, M.C., Bluethmann,plate-bound anti-CD3 in the absence of any additional reagents.
H., and Kohler, G. (1993). Disrupton of the murine IL-4 gene blocksSupernatants were collected 24 hr later. Cytokine ELISAs were per-
Th2 cytokine responses. Nature 362, 245±248.formed as previously described (Kuchroo et al., 1995).
Kotanides, H., and Reich, N.C. (1993). Requirement of tyrosine phos-
phorylation for rapid activation of a DNA binding factor by IL-4.Acknowledgments
Science 262, 1265±1267.
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Note Added in Proof
Similar observations have been made by Drs. Kishimoto, Akira, and
colleagues on mice selectively deficient in Stat6. We thank Drs.
Kishimoto and Akira for sharing such observations with us prior to
publication.
